LAKEWOOD, Colo., 12 May 2025 –

科罗拉多州莱克伍德，2025年5月12日 –

Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, announces that Join Parachute will be adopting the Rika™ Plasma Donation System, a next-generation plasma collection system engineered to streamline plasma collection and prioritize donor comfort.

Terumo Blood and Cell Technologies（Terumo BCT）是一家医疗技术公司，宣布Join Parachute将采用Rika™血浆捐赠系统，这是一种下一代血浆采集系统，旨在简化血浆采集流程并优先考虑捐赠者的舒适度。

Join Parachute's mission is helping the world gain access to more plasma, starting by rethinking the donation experience. By combining thoughtful technology with a donor-first philosophy, the company is working to build a more compassionate and efficient experience. The integration of Rika supports this vision, offering a fast, comfortable and efficient donation experience designed with both donors and patients in mind..

加入Parachute的使命是帮助世界获取更多血浆，首先从重新思考捐赠体验开始。通过将周到的技术与以捐赠者为优先的理念相结合，该公司正致力于打造一个更加富有同情心和高效的体验。Rika的整合支持了这一愿景，提供了一种快速、舒适且高效的捐赠体验，同时考虑到了捐赠者和患者的需求。

“Join Parachute is reimagining the future of plasma donation, and Rika helps make that vision real.” said Tim Costello, general manager Plasma Innovations at Terumo Blood and Cell Technologies. “Rika's advanced technology is designed to enable a more comfortable experience for donors, which contributes to repeat donations — essential to building a more reliable plasma supply for patients in need.

“加入Parachute正在重新构想血浆捐赠的未来，而Rika有助于实现这一愿景。” Terumo血液和细胞技术公司血浆创新部门总经理Tim Costello表示，“Rika的先进技术旨在为捐赠者提供更舒适的体验，这有助于促进重复捐赠——这对于为有需要的患者建立更可靠的血浆供应至关重要。”

It also reflects our broader commitment to advancing automation and going beyond equipment with connected technologies that help shape customer environments and transform business models.”.

这也反映了我们更广泛的承诺，即推动自动化的发展，并通过连接技术超越设备本身，这些技术有助于塑造客户环境并转变商业模式。

The Rika Plasma Donation System is purpose-built for donor comfort. The system’s iNomi™ Nomogram collects up to 1,000 mL of plasma, based on a donor’s hematocrit, weight and height, with an average collection time of less than 35 minutes. Additionally, iNomi enables plasma donors to donate an individualized amount of plasma on any given day based on height, weight and red blood cells in the donor’s blood.

Rika血浆捐赠系统专为捐赠者舒适度而设计。系统中的iNomi™诺模图根据捐赠者的红细胞比容、体重和身高，采集多达1000毫升的血浆，平均采集时间不到35分钟。此外，iNomi使血浆捐赠者能够根据身高、体重和血液中的红细胞数量，在任何一天捐赠个性化的血浆量。

With less than 200 mL of blood cells outside the donor’s body at any given time, should the initial procedure not be completed, the donor can return and donate without being deferred. Rika’s integrated control system further elevates the experience by guiding operators with real-time alerts and visual cues, allowing them to focus on donor care while Rika manages adjustments automatically..

在任何给定时间，体外的血细胞量少于200毫升，如果初始程序未完成，捐赠者可以返回并继续捐赠而不会被推迟。Rika的集成控制系统通过实时警报和视觉提示进一步提升了体验，使操作员能够专注于捐赠者护理，同时Rika自动进行调整。

Joshua Grosbard, chief executive officer at Join Parachute, said, “Integrating Rika into our operations reflects our commitment to creating a donation experience that is convenient and comfortable. The technology will help us deliver on our promise to donors while growing access to plasma-based therapies for those who need them most.”.

Join Parachute 首席执行官 Joshua Grosbard 表示：“将 Rika 整合到我们的运营中，体现了我们致力于打造便捷舒适的捐赠体验。这项技术将帮助我们兑现对捐赠者的承诺，同时扩大对最需要血浆疗法的患者的获取途径。”

This collaboration represents a shared commitment to innovation, human-centered design and expanding access to lifesaving therapies. Costello adds, “This is a practical example of how Terumo BCT continues to collaborate with forward-thinking organizations to meet evolving customer and patient needs.”.

这种合作代表了对创新、以人为本的设计和扩大获得救命疗法的共同承诺。科斯特洛补充说：“这是泰尔茂BCT公司如何继续与具有前瞻性的组织合作，以满足不断变化的客户和患者需求的一个实际例子。”

Rika™ and iNomi™ are either registered trademarks or trademarks of Terumo BCT, Inc in the United States and/or other countries. See

Rika™ 和 iNomi™ 是 Terumo BCT, Inc 在美国和/或其他国家的注册商标或商标。查看

TerumoBCT.com/Trademarks

TerumoBCT.com/商标

for details.

详情请参阅。

About Terumo Blood and Cell Technologies

关于特鲁莫血液和细胞技术

Terumo Blood and Cell Technologies is a medical technology company. Our products, software and services enable customers to collect and prepare blood and cells to help treat challenging diseases and conditions. Our employees worldwide believe in the potential of blood and cells to do even more for patients than they do today.

Terumo Blood and Cell Technologies 是一家医疗技术公司。我们的产品、软件和服务使客户能够收集和制备血液和细胞，以帮助治疗具有挑战性的疾病和病症。我们全球的员工相信血液和细胞有潜力为患者提供比今天更多的帮助。

This belief inspires our innovation and strengthens our collaboration with customers..

这种信念激发了我们的创新，并加强了我们与客户的合作。

Terumo Blood and Cell Technologies' customers include blood centers, hospitals, therapeutic apheresis clinics, cell collection and processing organizations, researchers and private medical practices. Our customers are based in over 150 countries across the globe. We have 750+ granted patents, with more than 150 additionally pending..

Terumo血液和细胞技术公司的客户包括血库中心、医院、治疗性单采诊所、细胞采集和处理机构、研究人员以及私人医疗机构。我们的客户遍布全球150多个国家。我们拥有750多项已授权专利，另有150多项专利正在申请中。

We have global headquarters in Lakewood, Colorado, U.S.A., along with five regional headquarters, eight manufacturing sites and six innovation and development centers across the globe. Terumo Blood and Cell Technologies is a subsidiary of Terumo Corporation (TSE: 4543), a global leader in medical technology..

我们在美国科罗拉多州莱克伍德设有全球总部，并在全球拥有五个区域总部、八个制造基地和六个创新研发中心。Terumo Blood and Cell Technologies 是 Terumo Corporation（东京证券交易所代码：4543）的子公司，该公司是全球医疗技术领域的领导者。

About Join Parachute

关于加入空投机

Join Parachute is dedicated to transforming the plasma donation experience through technology and donor-focused design. By simplifying the donation process and emphasizing donor comfort, Join Parachute aims to increase plasma donations and improve access to lifesaving therapies. Join Parachute operates source plasma collection centers in the U.S.

Join Parachute 致力于通过技术和以捐赠者为中心的设计来改变血浆捐赠体验。通过简化捐赠流程并强调捐赠者的舒适度，Join Parachute 旨在增加血浆捐赠量并改善对挽救生命疗法的获取。Join Parachute 在美国运营血浆采集中心。

and currently has 32 locations..

目前有 32 个地点。